Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim

被引：5
|
作者：
Nakazato, Tomonori [1 ]
Ito, Chisako [1 ]
Mihara, Ai [1 ]
Aisa, Yoshinobu [1 ]
机构：
[1] Yokohama Municipal Citizens Hosp, Dept Hematol, Hodogaya Ku, Yokohama, Kanagawa 2408555, Japan
来源：
INTERNATIONAL JOURNAL OF HEMATOLOGY | 2013年 / 97卷 / 02期
关键词：
ADULT PATIENTS; PURPURA; RESPONSES;
D O I：
10.1007/s12185-012-1253-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：291 / 293
页数：3
相关论文
共 50 条
  • [1] Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostim
    Tomonori Nakazato
    Chisako Ito
    Ai Mihara
    Yoshinobu Aisa
    [J]. International Journal of Hematology, 2013, 97 : 291 - 293
  • [2] The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim
    Al-Samkari, Hanny
    Schifferli, Alexandra
    Gonzalez-Lopez, Tomas J.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1143 - 1145
  • [3] Romiplostim plus danazol as salvage treatment for eltrombopag refractory immune thrombocytopenia: a retrospective pilot study
    Nam, Chang Hyun
    Byun, Ja Min
    Shin, Dong-Yeop
    Hong, Junshik
    Kim, Inho
    Yoon, Sung-Soo
    Koh, Youngil
    [J]. BLOOD RESEARCH, 2021, 56 (03) : 202 - 204
  • [4] Romiplostim and Eltrombopag in Immune Thrombocytopenia as a Second-Line Treatment
    Bidika, Erjola
    Fayyaz, Hafsa
    Salib, Marina
    Memon, Areeba N.
    Gowda, Asavari S.
    Rallabhandi, Bhavana
    Cancarevic, Ivan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [5] Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    [J]. BLOOD, 2018, 132
  • [6] Thrombopoietin level predicts response to treatment with eltrombopag and romiplostim in immune thrombocytopenia
    Al-Samkari, Hanny
    Kuter, David J.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1501 - 1508
  • [7] Cost-minimization analysis of immune thrombocytopenia treatment with romiplostim and eltrombopag
    Marzal Alfaro, M. B.
    Marquinez Alonso, I.
    Escudero Vilaplana, V.
    Pernia Lopez, S.
    Sanjurjo Saez, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 975 - 976
  • [8] Diagnosis of venous thromboembolism during eltrombopag therapy for immune thrombocytopenia and successful replacement with romiplostim
    Amit, O.
    Kirgner, I
    Avivi, I
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 606 - 607
  • [9] ROMIPLOSTIM AND ELTROMBOPAG FOR IMMUNE THROMBOCYTOPENIA: METHODS FOR INDIRECT COMPARISON
    Cooper, Katy L.
    Fitzgerald, Patrick
    Dillingham, Kerry
    Helme, Kawitha
    Akehurst, Ron
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2012, 28 (03) : 249 - 258
  • [10] Romiplostim as early treatment for refractory primary immune thrombocytopenia
    Contis, Anne
    Lazaro, Estibaliz
    Greib, Carine
    Pellegrin, Jean-Luc
    Viallard, Jean-Francois
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (05) : 520 - 524
12345